News on Calbiochem-Behring Australia from BioPortfolio.com http://www.BioPortfolio.com Consolidated Calbiochem-Behring Australia news from BioPortfolio.com Wed, 10 Feb 2010 04:33:12 GMT en Global SWIFT Studies Will Evaluate Safety and Efficacy of CSL Behring's Biostate(R) for von Willebrand Diseasehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019782&HITNO=0&MSIZE=4&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calbiochem-Behring%20Australia&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019782&THISHREF=http://c.moreover.com/click/here.pl%3fz2526477601%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019782&HITNO=0&MSIZE=4&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calbiochem-Behring%20Australia&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019782&THISHREF=http://c.moreover.com/click/here.pl%3fz2526477601%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmiWeb: Global SWIFT unveils new studyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020965&HITNO=1&MSIZE=4&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calbiochem-Behring%20Australia&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020965&THISHREF=http://c.moreover.com/click/here.pl%3fz2527075488%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020965&HITNO=1&MSIZE=4&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calbiochem-Behring%20Australia&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020965&THISHREF=http://c.moreover.com/click/here.pl%3fz2527075488%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Europe: CSL Behring launches Berinert Expert Network in USAhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3981120&HITNO=2&MSIZE=4&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calbiochem-Behring%20Australia&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3981120&THISHREF=http://c.moreover.com/click/here.pl%3fz2506783726%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3981120&HITNO=2&MSIZE=4&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calbiochem-Behring%20Australia&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3981120&THISHREF=http://c.moreover.com/click/here.pl%3fz2506783726%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBio Spectrum Asia: Class action against Australia's CSL widens with US university claimant; Medicines Australia appoints permanenhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3886097&HITNO=3&MSIZE=4&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calbiochem-Behring%20Australia&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3886097&THISHREF=http://c.moreover.com/click/here.pl%3fz2457630684%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3886097&HITNO=3&MSIZE=4&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Calbiochem-Behring%20Australia&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3886097&THISHREF=http://c.moreover.com/click/here.pl%3fz2457630684%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Letter: